GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 791 filers reported holding GLAXOSMITHKLINE PLC in Q2 2021. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $1,369,000 | -0.4% | 31,461 | -0.4% | 0.12% | +19.8% |
Q1 2022 | $1,375,000 | -4.2% | 31,573 | -3.0% | 0.10% | +9.8% |
Q4 2021 | $1,436,000 | +26.0% | 32,552 | +9.1% | 0.09% | +8.2% |
Q3 2021 | $1,140,000 | +1.2% | 29,839 | +5.5% | 0.08% | +26.9% |
Q2 2021 | $1,127,000 | +9.0% | 28,294 | -2.4% | 0.07% | +1.5% |
Q1 2021 | $1,034,000 | +5.1% | 28,982 | +8.3% | 0.07% | -32.7% |
Q4 2020 | $984,000 | +25.0% | 26,752 | +27.9% | 0.10% | +21.0% |
Q3 2020 | $787,000 | -6.4% | 20,915 | +1.4% | 0.08% | -16.5% |
Q2 2020 | $841,000 | +39.5% | 20,618 | +29.5% | 0.10% | +10.2% |
Q1 2020 | $603,000 | -31.6% | 15,927 | -15.0% | 0.09% | -8.3% |
Q4 2019 | $881,000 | +19.9% | 18,745 | +8.9% | 0.10% | +12.9% |
Q3 2019 | $735,000 | +8.1% | 17,215 | +1.4% | 0.08% | -1.2% |
Q2 2019 | $680,000 | +31.3% | 16,980 | +33.2% | 0.09% | +6.2% |
Q3 2017 | $518,000 | -17.8% | 12,750 | -12.8% | 0.08% | -57.1% |
Q2 2017 | $630,000 | -99.9% | 14,620 | +17.4% | 0.19% | +10.5% |
Q1 2017 | $524,892,000 | – | 12,450 | – | 0.17% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |